Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Medikamentöse Rückfallverhütung bei affektiven Störungen

  • Chapter
Die therapeutische Vielfalt in der Depressionsbehandlung

  • 53 Accesses

Zusammenfassung

Im Rahmen des WHO-Projektes „Global Burden of Disease“ wurde die medizinische und gesundheitspolitische Bedeutung der wichtigsten Volkskrankheiten weltweit untersucht.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent depressive disorders. Lancet 2: 326–330

    Article  PubMed  CAS  Google Scholar 

  • Baldessarini RJ, Tondo L, Hennen J (1999) Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 60 (S2): 77–84

    Article  PubMed  CAS  Google Scholar 

  • Bauer M, Bschor T, Kunz D, Berghofer A, Ströhle A, Müller-Oerlinghausen B (2000) Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 157: 1429–1435

    Article  PubMed  CAS  Google Scholar 

  • Bauer M, Ströhle A (1999) Behandlungsstrategien bei prophylaxeresistenten bipolaren Störungen. Nervenarzt 70: 587–599

    Article  PubMed  CAS  Google Scholar 

  • Bottlender R, Rudolf D, Strauss A, Möller HJ (2000) Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches into states of expansive syndromes (known in Germany as „maniform syndromes”) in bipolar I depression? Pharmacopsychiatry 33: 75–77

    Article  PubMed  CAS  Google Scholar 

  • Bowden CL, Calabrese JR, McElroy SL et al. (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57: 481–489

    CAS  Google Scholar 

  • Calabrese JR, Rapport DJ, Kimmel SE, Reece B, Woyshville MJ (1993) Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 38 (S2): S57–61

    PubMed  CAS  Google Scholar 

  • Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ (1996) Predictors of response to mood stabilizers. J Clin Psychopharmacol 16 (S1): 24S - 31S

    Article  PubMed  CAS  Google Scholar 

  • Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60: 79–88

    Article  PubMed  CAS  Google Scholar 

  • Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, Gardner R, Maggs R (1971) Prophylactic lithium in affective disorders. Controlled trial. Lancet 2: 275–279

    Google Scholar 

  • Coryell W, Solomon D, Leon AC, Akiskal HS, Keller MB, Scheftner WA, Mueller T (1998) Lithium discontinuation and subsequent effectiveness. Am J Psychiatry 155: 895–898

    PubMed  CAS  Google Scholar 

  • Cundall RL, Brooks PW, Murray LG (1972) A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 2: 308–311

    Article  PubMed  CAS  Google Scholar 

  • Dang T, Engel RR (1995) Long-term drug treatment of bipolar and depressive disorders: meta-analysis of controlled clinical trials with lithium, carbamazepine and antidepressive agents. Pharmacopsychiatry 28: 170

    Google Scholar 

  • Dardennes R, Even C, Bange F, Heim A (1995) Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders. A meta-analysis. Br J Psychiatry 166: 378–381

    Google Scholar 

  • Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM (1997) Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 58: 470–478

    Article  PubMed  CAS  Google Scholar 

  • Dunner DL, Stallone F, Fieve RR (1976) Lithium carbonate and affective disorders. V: A double- blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 33: 117–120

    Google Scholar 

  • Faravelli C, Ambonetti A, Pallanti S, Pazzagli A (1986) Depressive relapses and incomplete re- covery from index episode. Am J Psychiatry 143: 888–891

    PubMed  CAS  Google Scholar 

  • Fieve RR, Kumbaraci T, Dunner DL (1976) Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 133: 925–929

    PubMed  CAS  Google Scholar 

  • Fogelson DL, Sternbach H (1997) Lamotrigine treatment of refractory bipolar disorder. J Clin Psychiatry 58: 271–273

    Article  PubMed  CAS  Google Scholar 

  • Frank E, Kupfer DJ, Wagner EF, McEachran AB, Cornes C (1991) Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors. Arch Gen Psychiatry 48: 1053–1059

    Google Scholar 

  • Frank E, Kupfer DJ, Perel JM, Cornes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ (1993) Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 27: 139–145

    Article  PubMed  CAS  Google Scholar 

  • Frankenburg FR, Tohen M, Cohen BM, Lipinski JF Jr (1988) Long-term response to carbamazepine: a retrospective study. J Clin Psychopharmacol 8: 130–132

    Article  PubMed  CAS  Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Erazo N (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 40: 179–190

    Article  PubMed  CAS  Google Scholar 

  • Greil W, Ludwig-Mayerhofer W, Erazo N (1997) Lithium versus carbamazepine in the main- tenance treatment of bipolar disorders–a randomised study. J Affect Disord 43: 151–161

    Article  PubMed  CAS  Google Scholar 

  • Hullin RP, McDonald R, Allsopp MN (1972) Prophylactic lithium in recurrent affective disorders. Lancet 13 (1): 1044–1046

    Article  Google Scholar 

  • Juckel G, Hegerl U, Mavrogiorgou P (2000) Clinical and biological findings in a case with 48-hour bipolar ultrarapid cycling before and during valproate treatment. J Clin Psychiatry 61: 585–593

    Article  PubMed  CAS  Google Scholar 

  • Kusumakar V, Yatham LN (1997) An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 72: 145–148

    Article  PubMed  CAS  Google Scholar 

  • Maj M (2000) The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disorders 2: 92–101

    Article  Google Scholar 

  • McElroy SL, Keck PE Jr (2000) Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 48: 539–557

    Article  PubMed  CAS  Google Scholar 

  • Melia PI (1970) Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 116: 621–624

    Article  PubMed  CAS  Google Scholar 

  • Möller HJ, Grunze H (2000) Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 250: 57–68

    Article  PubMed  Google Scholar 

  • Murray CI, Lopez AD (1997) The global burden of disease in 1990: final results and their sensitivity to alternative epidemiological perspectives, discount rates, age-weights and disability weights. In: Murray CJ, Lopez AD (eds) The global burden of disease. Global burden of disease and injury series, vol I. Harvard University Press, Harvard, pp 247–293

    Google Scholar 

  • Okuma T (1993) Effects of carbamazepine and lithium on affective disorders. Neuropsychobiology 27: 138–145

    Article  PubMed  CAS  Google Scholar 

  • Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–550

    Article  PubMed  CAS  Google Scholar 

  • Prien RF, Gaffey EM Jr, Klett CJ (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiatry 28: 337–341

    Google Scholar 

  • Post RM, Leverich GS, Altshuler L, Mikalauskas K (1992) Lithium-discontinuation-induced refractoriness: preliminary observations. Am J Psychiatry 149: 1727–1729

    PubMed  CAS  Google Scholar 

  • Post RM, Ketter TA, Denicoff K et al. (1996) Frye MA. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128: 115–129

    Article  PubMed  CAS  Google Scholar 

  • Reynolds CF 3rd, Frank E, Perel JM et al. (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281: 39–45

    Article  PubMed  CAS  Google Scholar 

  • Rouillon F, Gorwood P (1998) The use of lithium to augment antidepressant medication. J Clin Psychiatry 59 (S5): 32–39

    PubMed  CAS  Google Scholar 

  • Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46: 739–746

    Article  PubMed  CAS  Google Scholar 

  • Schaffer CB, Schaffer LC (1997) Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 154: 291–292

    PubMed  CAS  Google Scholar 

  • Stallone F, Shelley E, Mendlewicz J, Fieve RR (1973) The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 130: 1006–1010

    Google Scholar 

  • Stancer HG, Persad E (1982) Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Clinical observations. Arch Gen Psychiatry 39: 311–312

    Google Scholar 

  • Terra JL, Montgomery SA (1998) Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharmacol 13: 55–62

    Article  PubMed  CAS  Google Scholar 

  • Tondo L, Jamison KR, Baldessarini RJ (1997) Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci 836: 339–351

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. U. Hegerl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Pogarell
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik für Psychiatrie und Psychotherapie, Osianderstr. 24, 72076, Tübingen, Deutschland

    A. Batra  & G. Buchkremer  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hegerl, U., Pogarell, O. (2001). Medikamentöse Rückfallverhütung bei affektiven Störungen. In: Batra, A., Buchkremer, G. (eds) Die therapeutische Vielfalt in der Depressionsbehandlung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59494-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59494-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42072-9

  • Online ISBN: 978-3-642-59494-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation